PCN105 COST-UTILITY OF NIVOLUMAB FOR RECURRENT OR METASTATIC HEAD AND NECK CANCER (R/M SCCHN) IN FRANCE
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.302
https://www.valueinhealthjournal.com/article/S1098-3015(19)32680-4/fulltext
Title :
PCN105 COST-UTILITY OF NIVOLUMAB FOR RECURRENT OR METASTATIC HEAD AND NECK CANCER (R/M SCCHN) IN FRANCE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)32680-4&doi=10.1016/j.jval.2019.09.302
First page :
Section Title :
Open access? :
No
Section Order :
10246